Loading...
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
PURPOSE: Trastuzumab and chemotherapy is the current standard of care in HER2+ early or locally advanced breast cancer, but there are scanty literature data of its real world effectiveness. METHODS: We retrospectively reviewed 205 patients with HER2+ breast cancer diagnosed in 10 Italian Medical Onc...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer-Verlag
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3678021/ https://ncbi.nlm.nih.gov/pubmed/23604446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-013-1436-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|